STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer

Li,Jie; Cui,Geng; Sun,Lu; Wang,Shu-Juan; Li,Ya-Li; Meng,Yuan-Guang; Guan,Zheng; Fan,Wen-Sheng; Li,Li-An; Yang,Yi-Zhuo; You,Yan-Qin; Fu,Xiao-Yu; Yan,Zhi-Feng; Huang,Ke

doi:10.3892/or.2013.2414

STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer

Authors:
- Jie Li
- Geng Cui
- Lu Sun
- Shu-Juan Wang
- Ya-Li Li
- Yuan-Guang Meng
- Zheng Guan
- Wen-Sheng Fan
- Li-An Li
- Yi-Zhuo Yang
- Yan-Qin You
- Xiao-Yu Fu
- Zhi-Feng Yan
- Ke Huang
View Affiliations

Affiliations: Department of Gynecology and Obstetrics, General Hospital of PLA, Beijing 100853, P.R. China, Department of Orthopedics, General Hospital of PLA, Beijing 100853, P.R. China, Department of Pathology, General Hospital of PLA, Beijing 100853, P.R. China
Published online on: April 22, 2013 https://doi.org/10.3892/or.2013.2414
Pages: 165-170

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

ARHI is a Ras-related imprinted tumor-suppressor gene that inhibits cancer cell growth and motility. ARHI is downregulated in the majority of ovarian cancer cells, and promoter methylation is considered to be associated with its loss of expression. however, the underlying mechanisms are not well understood. Thus, the present study aimed to investigate the specific functions of ARHI and its methylation in ovarian cancer cell proliferation. Furthermore, we examined the possible role of acetylated STAT3 in modulating the expression of ARHI and its methylation. In accordance with the majority of previous studies, reduced ARHI expression was found in epithelial ovarian cancer tissues and cancer cell lines as indicated by immunohistochemistry and RT-PCR. In addition, CpG islands Ⅰ and Ⅱ within ARHI promoter regions were partially methylated or hypermethylated in cancer cell lines (SKOV-3 and HO-8910) as analyzed by pyrosequencing assays, resulting in enhanced proliferation of the cancer cells. This proliferation was reversed by the administration of 5-aza-2'-deoxycytidine. Subsequently, we demonstrated that STAT3 acetylation was increased in HO-8910 cells, and the methylation status of CpG Ⅰ was altered in response to the acetylation of STAT3 using western blotting. Finally, chromatin immunoprecipitation (ChIP) and IP analysis indicated that acetylated STAT3 bound to the ARHI promoter and recruited DNA methyltransferase 1 for genetic modification. In conclusion, acetylated STAT3-induced promoter gene methylation accounts for the loss of ARHI expression and cancer cell proliferation.

View Figures

View References

1	Yu Y, Xu F, Peng H, et al: NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA. 96:214–219. 1999. View Article : Google Scholar : PubMed/NCBI
2	Peng H, Xu F, Pershad R, et al: ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. Int J Cancer. 86:690–694. 2000. View Article : Google Scholar : PubMed/NCBI
3	Luo RZ, Fang X, Marquez R, et al: ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene. 22:2897–2909. 2003. View Article : Google Scholar : PubMed/NCBI
4	Zhao X, Li J, Zhuo J and Cai L: Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma. Biochem Biophys Res Commun. 403:417–421. 2010. View Article : Google Scholar : PubMed/NCBI
5	Zou CF, Jia L, Jin H, et al: Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. BMC Cancer. 11:222011. View Article : Google Scholar : PubMed/NCBI
6	Yang H, Lu X, Qian J, et al: Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells. Mol Med Rep. 3:581–587. 2010.PubMed/NCBI
7	Kobayashi H, Kajiwara H, Kanayama S, et al: Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review). Oncol Rep. 22:233–240. 2009.PubMed/NCBI
8	Luo RZ, Peng H, Xu F, et al: Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochim Biophys Acta. 1519:216–222. 2001. View Article : Google Scholar : PubMed/NCBI
9	Feng W, Marquez RT, Lu Z, et al: Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer. 112:1489–1502. 2008. View Article : Google Scholar : PubMed/NCBI
10	Yuan Z, Guan Y, Chatterjee D and Chin YE: Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science. 307:269–273. 2005. View Article : Google Scholar : PubMed/NCBI
11	Wang R, Cherukuri P and Luo J: Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. J Biol Chem. 280:11528–11534. 2005. View Article : Google Scholar : PubMed/NCBI
12	Kimura K, Yamada T, Matsumoto M, et al: Endoplasmic reticulum stress inhibits STAT3-dependent suppression of hepatic gluconeogenesis via dephosphorylation and deacetylation. Diabetes. 61:61–73. 2012. View Article : Google Scholar : PubMed/NCBI
13	Morgan RJ, Alvarez RD, Armstrong DK, et al: Epithelial ovarian cancer. J Natl Compr Cancer Netw. 9:82–113. 2011.
14	Higashiura Y, Kajihara H, Shigetomi H and Kobayashi H: Identification of multiple pathways involved in the malignant transformation of endometriosis (Review). Oncol Lett. 4:3–9. 2012.PubMed/NCBI
15	Lee H, Zhang P, Herrmann A, et al: Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci USA. 109:7765–7769. 2012. View Article : Google Scholar : PubMed/NCBI
16	Yuan J, Luo RZ, Fujii S, et al: Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res. 63:4174–4180. 2003.PubMed/NCBI
17	Sharda DR, Yu S, Ray M, et al: Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase. J Immunol. 187:2181–2192. 2011. View Article : Google Scholar : PubMed/NCBI
18	Badgwell DB, Lu Z, Le K, et al: The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. Oncogene. 31:68–79. 2012. View Article : Google Scholar : PubMed/NCBI
19	Bao JJ, Le XF, Wang RY, et al: Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res. 62:7264–7272. 2002.PubMed/NCBI
20	Lu Z, Luo RZ, Peng H, et al: Transcriptional and post-transcriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res. 12:2404–2413. 2006. View Article : Google Scholar : PubMed/NCBI
21	Qidwai MT, Jamal F, Singh D and Sharma RK: Factors modifying transcriptional regulation of signaling genes have putative role in tumor development and progression in humans. Med Hypotheses. 79:805–812. 2012. View Article : Google Scholar : PubMed/NCBI
22	Stark GR, Wang Y and Lu T: Lysine methylation of promoter-bound transcription factors and relevance to cancer. Cell Res. 21:375–380. 2011. View Article : Google Scholar : PubMed/NCBI
23	Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T and Wasik MA: STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci USA. 102:6948–6953. 2005. View Article : Google Scholar : PubMed/NCBI